Article info
Letter
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy
- Correspondence to Professor Olivier Lambotte, CHU Bicêtre, APHP, Department of Internal Medicine and Clinical Immunology, 78 rue du Général Leclerc, Le Kremlin-Bicêtre F-94275, France; olivier.lambotte{at}aphp.fr
Citation
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy
Publication history
- Received November 13, 2016
- Revised January 26, 2017
- Accepted February 6, 2017
- First published February 27, 2017.
Online issue publication
April 19, 2018
Article Versions
- Previous version (12 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/